Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mucinex, Zyrtec Online Strategies Score While Most OTC Brands Miss

This article was originally published in The Tan Sheet

Executive Summary

RB's Mucinex brand ranks highest among OTC drug brands evaluated in digital research firm L2’s Digital IQ Index, which found the OTC sector ranked last in digital ad spend among the top 10 industries. OTC product brands tend to be unsophisticated online and do not adequately link products to points of purchase.

You may also be interested in...



Year-Round Vicks Advertising Part of P&G's Greater Reach Strategy

P&G’s Vicks brand will advertise year round since 40% of colds hit during times other than winter, P&G Chief Brand Officer Marc Pritchard says. The strategy also is part of the firm’s push to grow media reach for certain brands by as much as 20%.

Year-Round Vicks Advertising Part of P&G's Greater Reach Strategy

P&G’s Vicks brand will advertise year round since 40% of colds hit during times other than winter, P&G Chief Brand Officer Marc Pritchard says. The strategy also is part of the firm’s push to grow media reach for certain brands by as much as 20%.

Sinex Says 'Clear Your Head' To Launch Oral Dosage, Mist Sprays

P&G will promote its re-launched Vicks Sinex nasal decongestant brand with an ad campaign that will feature the tagline, “The Clear Your Head Medicine.”

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS108228

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel